482 related articles for article (PubMed ID: 2572694)
1. Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs.
Bowden CR; Marchione CS
J Pharmacol Exp Ther; 1989 Nov; 251(2):599-605. PubMed ID: 2572694
[TBL] [Abstract][Full Text] [Related]
2. Effects of 1-(4-nitrophenyl)-2-isopropylaminoethanol (INPEA) and propranolol and their dextro-isomers on hemodynamic and metabolic responses to isoproterenol in dogs.
Nishimura T; Kita S; Abiko Y
J Pharmacol Exp Ther; 1983 Aug; 226(2):595-602. PubMed ID: 6688273
[TBL] [Abstract][Full Text] [Related]
3. Relationship between the sympatholytic action of nebivolol and hypotension.
Ward JE; Coles P; Cox H; Eisenhofer G; Angus JA
J Cardiovasc Pharmacol; 1992 Jul; 20(1):115-24. PubMed ID: 1383620
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of nebivolol, atenolol and propranolol on heart rate and on bronchoconstrictor responses to histamine in the guinea-pig.
De Clerck F; Van Gorp L; Loots W; Janssen PA
Arch Int Pharmacodyn Ther; 1989; 298():230-6. PubMed ID: 2569298
[TBL] [Abstract][Full Text] [Related]
5. Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292.
Smith HJ; Halliday SE; Earl DC; Stribling D
J Pharmacol Exp Ther; 1983 Jul; 226(1):211-6. PubMed ID: 6134820
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the beta1-selectivity of three beta1-selective beta-blockers.
Nuttall SL; Routledge HC; Kendall MJ
J Clin Pharm Ther; 2003 Jun; 28(3):179-86. PubMed ID: 12795776
[TBL] [Abstract][Full Text] [Related]
7. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection.
Mahmud A; Feely J
Am J Hypertens; 2008 Jun; 21(6):663-7. PubMed ID: 18437130
[TBL] [Abstract][Full Text] [Related]
8. Beta-blockade with nebivolol enhances the acetylcholine-induced cutaneous vasodilation.
Kubli S; Feihl F; Waeber B
Clin Pharmacol Ther; 2001 Apr; 69(4):238-44. PubMed ID: 11309552
[TBL] [Abstract][Full Text] [Related]
9. Integrated effects of the vasodilating beta-blocker nebivolol on exercise performance, energy metabolism, cardiovascular and neurohormonal parameters in physically active patients with arterial hypertension.
Predel HG; Mainka W; Schillings W; Knigge H; Montiel J; Fallois J; Agrawal R; Schramm T; Graf C; Giannetti BM; Bjarnason-Wehrens B; Prinz U; Rost RE
J Hum Hypertens; 2001 Oct; 15(10):715-21. PubMed ID: 11607802
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of nebivolol.
Janssens WJ
J Pharm Belg; 1992; 47(4):323-7. PubMed ID: 1357130
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the subacute hemodynamic effects of atenolol, propranolol, pindolol, and nebivolol.
De Crée J; Cobo C; Geukens H; Verhaegen H
Angiology; 1990 Feb; 41(2):95-105. PubMed ID: 1968323
[TBL] [Abstract][Full Text] [Related]
12. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL
J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598
[TBL] [Abstract][Full Text] [Related]
13. Adrenoceptors mediating metabolic responses in the greyhound.
Kelly JG; Shanks RG
Br J Pharmacol; 1971 Feb; 41(2):389P-390P. PubMed ID: 4396705
[No Abstract] [Full Text] [Related]
14. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
von Fallois J; Faülhaber HD
Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
[TBL] [Abstract][Full Text] [Related]
15. Comparative metabolic and cardiovascular effects of carbuterol, isoproterenol, metaproterenol and salbutamol in the baboon.
Potter DE; Woodson LC; Kempen RR; Ellis S
Horm Metab Res; 1980 Jul; 12(7):323-7. PubMed ID: 6105120
[TBL] [Abstract][Full Text] [Related]
16. Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol.
Ignarro LJ
Cardiovasc Ther; 2008; 26(2):115-34. PubMed ID: 18485134
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of dl-nebivolol and its enantiomers--a comparison with those of atenolol.
Van de Water A; Xhonneux R; Reneman RS; Janssen PA
Eur J Pharmacol; 1988 Oct; 156(1):95-103. PubMed ID: 3208842
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial.
Grassi G; Trevano FQ; Facchini A; Toutouzas T; Chanu B; Mancia G
Blood Press Suppl; 2003 Dec; 2():35-40. PubMed ID: 14761075
[TBL] [Abstract][Full Text] [Related]
19. Effect of nebivolol on cardiovascular changes associated with a rat model of insulin-resistance.
Renna N; Risler N; Cruzado M; Gonzalez S; Lama C; Miatello RM
Cell Mol Biol (Noisy-le-grand); 2005 Nov; 51(6):531-7. PubMed ID: 16309577
[TBL] [Abstract][Full Text] [Related]
20. Exercise tolerance with nebivolol and atenolol.
Van Bortel LM; van Baak MA
Cardiovasc Drugs Ther; 1992 Jun; 6(3):239-47. PubMed ID: 1353367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
